The SGLT2 inhibitor empagliflozin does not stimulate compensatory appetite responses in patients with excess adiposity and type 2 diabetes [Abstract]

No description supplied

Saved in:
Bibliographic Details
Main Authors: Melanie Davies, Emma Baldry, Danielle Bodicoat, Sudesna Chatterjee, Charlotte Edwardson, Laura Gray, Kamlesh Khunti, Jack Sargeant, David Stensel, David Webb, John Wilding, Scott Willis, Tom Yates, James King
Format: Default Conference proceeding
Published: 2020
Subjects:
Uncategorised value
Online Access:https://hdl.handle.net/2134/12377810.v1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://hdl.handle.net/2134/12377810.v1

Similar Items